Advertisement

Topics

Oxford BioTherapeutics (OBT) Company Profile

16:11 EDT 23rd September 2017 | BioPortfolio

Oxford BioTherapeutics (OBT) is focused on the development of targeted antibody medicines for oncology. OBT's strategy is to develop innovative antibody-based cancer drugs, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP(R) proteomic database. OBT is in an unrivalled position to convert its novel targets into a successful therapeutic pipeline through its alliances with the world leaders in antibody development (Medarex, Biosite and Amgen). OBT's current antibody pipeline is expected to deliver innovative and cost-effective medicines to fulfil major unmet patient needs in the field of cancer. OBT, a privately held company, was formed in 2004 and is based near Oxford, UK.


News Articles [484 Associated News Articles listed on BioPortfolio]

Oncology Research: New Opportunities For Menarini Group And Oxford BioTherapeutics

  Life Sciences Jobs   ...

Oxford BioTherapeutics Appoints Senior Clinical Biotech Executive as Non-Executive Director

OXFORD, England and SAN JOSE, California, June 13, 2017 /PRNewswire/ -- Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjuga...

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

New light on the secret life of badgers

(University of Oxford) Badgers are more sociable than often thought, with implications for how they transmit disease, new Oxford University research reveals. Using security tracking technology more co...

Menarini and OBT conduct Phase I oncology trial of MEN1309

Italian pharmaceutical company Menarini Ricerche has partnered with UK-based biotechnology firm Oxford BioTherapeutics (OBT) to conduct a Phase I clinical trial of MEN1309 to treat patients with metas...

#jobs #lifescience Immunocore: Early Diagnostic Senior Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Early Diagnostic Senior Scientist – Oxford . Competitive sa...

New exec director

Milton Park-based Oxford BioTherapeutics has welcomed Dr John McHutchison, executive vice president in clinical research for Gilead Sciences, to its board. Dr McHutchison has 20 years' clinical an...

Oncology Research: New Opportunities for Menarini and OBT

POMEZIA, Italy and OXFORD, England, September 12, 2017 /PRNewswire/ -- Menarini Ricerche (Menarini Group) and Oxford BioTherapeutics (OBT), an international biotechnology company, announce today t...

Drugs and Medications [14 Associated Drugs and Medications listed on BioPortfolio]

Plasmanate [TALECRIS BIOTHERAPEUTICS, INC.]

Plasma Protein Fraction (Human) 5%, USPPlasmanate®

Gamastan s/d [TALECRIS BIOTHERAPEUTICS, INC.]

Immune Globulin (Human)GamaSTAN™ S/DSolvent/Detergent Treated

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 20%, USPPlasbumin®-20

PubMed Articles [625 Associated PubMed Articles listed on BioPortfolio]

TILT Biotherapeutics.

The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.

The Oxford Classification for Immunoglobulin A nephropathy (IgAN) identifies pathological variables that may predict the decline of renal function. This study aimed to evaluate the Oxford Classificati...

Book Reviews Pharmacology and Therapeutics of Asthma and COPD Edited by Clive P Page , Peter J Barnes Springer 2017 Price £278.50. Pp 285 ISBN 978 3 319 52173 2 Oxford Handbook of Infectious Diseases and Microbiology ( 2nd edn ) Estee Torok , Ed Moran , Fiona Cooke Oxford University Press 2016 Price £34.99. Pp 879 ISBN 978 0 19 9671328 Anaesthesia for the Elderly Patient ( 2nd edn ) Chris Dodds

Book ReviewsReviews.

Michael S. Gazzaniga, Richard B. Ivry and George R. Mangun Cognitive neuroscience: The biology of the mind (International student edition) (4th ed.) Trevor W. Robbins, Barry J. Everitt and David J. Nu...

Five-year clinical and radiological outcomes in 257 consecutive cementless Oxford medial unicompartmental knee arthroplasties.

Our aim was to examine the clinical and radiographic outcomes in 257 consecutive Oxford unicompartmental knee arthroplasties (OUKAs) (238 patients), five years post-operatively.

Clinical Trials [74 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

A Clinical Investigation of the Oxford® Partial Knee System

The purpose of this prospective data collection is to document the performance and clinical outcomes of the Oxford® Partial Knee System.

Companies [189 Associated Companies listed on BioPortfolio]

Oxford BioTherapeutics (OBT)

Oxford BioTherapeutics (OBT) is focused on the development of targeted antibody medicines for oncology. OBT's strategy is to develop innovative antibody-based cancer drugs, with integrated diagnos...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

More Information about "Oxford BioTherapeutics (OBT)" on BioPortfolio

We have published hundreds of Oxford BioTherapeutics (OBT) news stories on BioPortfolio along with dozens of Oxford BioTherapeutics (OBT) Clinical Trials and PubMed Articles about Oxford BioTherapeutics (OBT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford BioTherapeutics (OBT) Companies in our database. You can also find out about relevant Oxford BioTherapeutics (OBT) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record